Vicci L. Korman

730 total citations
13 papers, 606 citations indexed

About

Vicci L. Korman is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Vicci L. Korman has authored 13 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 3 papers in Cancer Research. Recurrent topics in Vicci L. Korman's work include RNA Interference and Gene Delivery (5 papers), Cardiomyopathy and Myosin Studies (5 papers) and Cardiovascular Effects of Exercise (4 papers). Vicci L. Korman is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Cardiomyopathy and Myosin Studies (5 papers) and Cardiovascular Effects of Exercise (4 papers). Vicci L. Korman collaborates with scholars based in United States, Canada and Poland. Vicci L. Korman's co-authors include Larry S. Tobacman, Gretchen M. Unger, Betsy T. Kren, Roger Craig, William Lehman, Victoria Hatch, Michael Rosol, Jennifer E. Van Eyk, Robin Maytum and Michael A. Geeves and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Vicci L. Korman

13 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vicci L. Korman United States 12 416 271 102 87 80 13 606
Maia Vinogradova United States 10 374 0.9× 336 1.2× 90 0.9× 77 0.9× 28 0.3× 15 645
Young Hwa Song South Korea 13 459 1.1× 38 0.1× 302 3.0× 76 0.9× 35 0.4× 20 625
Nick Menhart United States 16 460 1.1× 31 0.1× 80 0.8× 44 0.5× 51 0.6× 34 657
Erica Wilson United Kingdom 13 318 0.8× 85 0.3× 76 0.7× 159 1.8× 63 0.8× 19 729
Stephen Burbeck United States 9 279 0.7× 93 0.3× 136 1.3× 35 0.4× 39 0.5× 12 410
Nick J. Dibb United Kingdom 9 482 1.2× 84 0.3× 39 0.4× 64 0.7× 30 0.4× 10 643
Lin Tong United States 8 447 1.1× 21 0.1× 65 0.6× 113 1.3× 20 0.3× 16 618
Tiila R. Kiema Finland 8 414 1.0× 33 0.1× 361 3.5× 27 0.3× 36 0.5× 9 785
Vikas Bhat United States 14 380 0.9× 20 0.1× 77 0.8× 74 0.9× 164 2.0× 33 525
Natalie L. Stephenson United Kingdom 10 501 1.2× 14 0.1× 69 0.7× 107 1.2× 28 0.3× 15 676

Countries citing papers authored by Vicci L. Korman

Since Specialization
Citations

This map shows the geographic impact of Vicci L. Korman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicci L. Korman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicci L. Korman more than expected).

Fields of papers citing papers by Vicci L. Korman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicci L. Korman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicci L. Korman. The network helps show where Vicci L. Korman may publish in the future.

Co-authorship network of co-authors of Vicci L. Korman

This figure shows the co-authorship network connecting the top 25 collaborators of Vicci L. Korman. A scholar is included among the top collaborators of Vicci L. Korman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicci L. Korman. Vicci L. Korman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ahmed, Khalil, Betsy T. Kren, Md. Joynal Abedin, et al.. (2016). CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors. Oncotarget. 7(38). 61789–61805. 15 indexed citations
2.
Unger, Gretchen M., Betsy T. Kren, Vicci L. Korman, et al.. (2014). Mechanism and Efficacy of Sub–50-nm Tenfibgen Nanocapsules for Cancer Cell–Directed Delivery of Anti-CK2 RNAi to Primary and Metastatic Squamous Cell Carcinoma. Molecular Cancer Therapeutics. 13(8). 2018–2029. 25 indexed citations
3.
Trembley, Janeen H., Gretchen M. Unger, Vicci L. Korman, et al.. (2014). Tenfibgen Ligand Nanoencapsulation Delivers Bi-Functional Anti-CK2 RNAi Oligomer to Key Sites for Prostate Cancer Targeting Using Human Xenograft Tumors in Mice. PLoS ONE. 9(10). e109970–e109970. 16 indexed citations
4.
Trembley, Janeen H., Gretchen M. Unger, Vicci L. Korman, et al.. (2014). Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation.. PubMed. 6(2). 15–25. 10 indexed citations
5.
Trembley, Janeen H., Gretchen M. Unger, Vicci L. Korman, et al.. (2011). Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α′ subunits reduces orthotopic xenograft prostate tumors in mice. Molecular and Cellular Biochemistry. 356(1-2). 21–35. 33 indexed citations
6.
Trembley, Janeen H., Gretchen M. Unger, Vicci L. Korman, et al.. (2011). Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells. Cancer Letters. 315(1). 48–58. 30 indexed citations
7.
Brown, Matthew S., Michael Y. Hu, Reza Ehsanian, et al.. (2010). CK2 Modulation of NF-κB, TP53, and the Malignant Phenotype in Head and Neck Cancer by Anti-CK2 Oligonucleotides In vitro or In vivo via Sub–50-nm Nanocapsules. Clinical Cancer Research. 16(8). 2295–2307. 71 indexed citations
8.
Kren, Betsy T., Gretchen M. Unger, Vicci L. Korman, et al.. (2009). Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice. Journal of Clinical Investigation. 119(7). 2086–99. 88 indexed citations
9.
Thomas, David D., David J. Kast, & Vicci L. Korman. (2009). Site-Directed Spectroscopic Probes of Actomyosin Structural Dynamics. Annual Review of Biophysics. 38(1). 347–369. 36 indexed citations
10.
Korman, Vicci L., et al.. (2005). Structural Dynamics of the Actin–Myosin Interface by Site-directed Spectroscopy. Journal of Molecular Biology. 356(5). 1107–1117. 20 indexed citations
11.
Lehman, William, Victoria Hatch, Vicci L. Korman, et al.. (2000). Tropomyosin and actin isoforms modulate the localization of tropomyosin strands on actin filaments. Journal of Molecular Biology. 302(3). 593–606. 219 indexed citations
12.
Korman, Vicci L., et al.. (2000). An Actin Subdomain 2 Mutation That Impairs Thin Filament Regulation by Troponin and Tropomyosin. Journal of Biological Chemistry. 275(29). 22470–22478. 20 indexed citations
13.
Korman, Vicci L. & Larry S. Tobacman. (1999). Mutations in Actin Subdomain 3 That Impair Thin Filament Regulation by Troponin and Tropomyosin. Journal of Biological Chemistry. 274(32). 22191–22196. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026